Are There Any Clinical Applications of Glucose Transporters in Cancer Diagnosis?
Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) exploits the high glucose uptake of cancer cells for diagnostic imaging. GLUT1-mediated uptake of 18F-FDG allows for the visualization of tumors and the assessment of treatment response. PET imaging has become a standard tool in oncology for the detection, staging, and monitoring of various cancers.
